Clinical

Dataset Information

0

Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer


ABSTRACT: This phase II trial is studying dasatinib to see how well it works in treating patients with previously treated metastatic colorectal cancer. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth.

DISEASE(S): Stage Iv Colon Cancer,Recurrent Colon Cancer,Rectal Neoplasms,Stage Iv Rectal Cancer,Recurrent Rectal Cancer,Colonic Neoplasms

PROVIDER: 2042300 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2034309 | ecrin-mdr-crc
| 2050120 | ecrin-mdr-crc
| 2322001 | ecrin-mdr-crc
| 2067339 | ecrin-mdr-crc
| 2140889 | ecrin-mdr-crc
| 2035047 | ecrin-mdr-crc
2013-11-27 | GSE39073 | GEO
2013-11-27 | E-GEOD-39073 | biostudies-arrayexpress
2021-04-30 | GSE147240 | GEO
2016-11-01 | GSE69395 | GEO